Beasley Allen
in
Pharmaceutical
NewsArticles 271 to 280 of 323 in the Pharmaceutical section.
Andy Birchfield, a Shareholder with the Montgomery law firm Beasley, Allen, Crow, Methvin, Portis and Miles, P.C. will appear on 60 minutes on Sunday, November 14th.
Attorneys representing 39 U.S. law firms met at a New Orleans restaurant and chose two lawyers to lead federal lawsuits against Merck & Co. on behalf of people claiming injuries because of the company’s Vioxx painkiller.
Merck & Co. Chief Executive Officer Raymond Gilmartin said Monday his first indication that the painkiller Vioxx carried a heart risk came on Sept. 23, and the company withdrew the medicine a week later.
Merck has begun "offering explanations" for internal documents that allegedly indicated the company was aware of the safety risks of the CQX-2 inhibitor Vioxx years before the voluntary withdrawal of the medication in late September, the Wall Street Journal reports (Martinez, Wall Street J…
Attorney Andy Birchfield Jr. is directing litigation against Merck &Co. by people who alleged that the painkiller caused heart attacks or strokes.
Attorneys involved in Vioxx litigation predict that all federal cases will be consolidated and transferred to a single venue soon after the Judicial Panel on Multidistrict Litigation meets in January.
Merck & Co. Chief Executive Officer Raymond Gilmartin said his first indication
Attorney Andy Birchfield Jr. is directing litigation against Merck & Co. by people who alleged that the painkiller caused heart attacks or strokes.
Merck & Co. Chief Executive Officer Raymond Gilmartin said his first indication that the painkiller Vioxx carried a heart risk came on Sept. 23, 2004 and the company withdrew the medicine a week later.
Attorneys involved in Vioxx litigation predict that all federal cases will be consolidated and transferred to a single venue soon after the Judicial Panel on Multi-district Litigation meet.